Hemorrhoids
Also known as: Piles
Methodology & AI Transparency ⓘ
Hemorrhoids Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are hemorrhoids? Hemorrhoids are swollen, inflamed veins around your anus or the lower part of your rectum .
- 2 Real-world patient consensus: Diagnostic registry K64.9: Hemorrhoids is managed within IBS, IBD & Colon (aka Piles).
- 3 Typical cash cost range: Clinicians assessing Hemorrhoids focus on mucosal tight-junction permeability in Hemorrhoids (K64.9: shifts or immune-mediated) and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in Hemorrhoids: maintaining Tissue Transglutaminase IgA in Hemorrhoids (K64.9: (tTG-IgA)) within Negative (celiac rule-out) (K64.9).
Ask our AI Specialists anything about Hemorrhoids
What Is Hemorrhoids?
What are hemorrhoids? Hemorrhoids are swollen, inflamed veins around your anus or the lower part of your rectum . There are two types: External hemorrhoids, which form under the skin around your anus Internal hemorrhoids, which form in the lining of your anus and lower rectum What causes hemorrhoids? Hemorrhoids happen when there is too much pressure on the veins around the anus. This can be caused by: Straining during bowel movements . Sitting on the toilet for long periods of time. Chronic constipation or diarrhea . A low- fiber diet. Weakening of the supporting tissues in your anus and rectum. This can happen with aging and pregnancy .
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Hemorrhoids (K64.9) features mucosal tight-junction permeability in Hemorrhoids (K64.9: shifts or immune-mediated). Cross-referenced with NIH MeSH (Hemorrhoids), therapeutic stabilization in ibs, ibd & colon is verified against hs-CRP, CBC & in Hemorrhoids (K64.9: Ferritin).
Common Symptoms & Clinical Signs
- • External hemorrhoids, which form under the skin around your anus
- • Internal hemorrhoids, which form in the lining of your anus and lower rectum
- • Presentation of Hemorrhoids (K64.9): alternating diarrhea, constipation, in Hemorrhoids (K64.9: urgency, or sensation)
- • Secondary Hemorrhoids clinical sign: post-meal abdominal distension, in Hemorrhoids (K64.9: gas bloating, or)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Hemorrhoids Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K64.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | IBS, Crohn, Colitis & Bowel Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Tissue Transglutaminase IgA in Hemorrhoids (K64.9: (tTG-IgA)) | Negative (celiac rule-out) (K64.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: hs-CRP, CBC & in Hemorrhoids (K64.9: Ferritin) | Normal hemoglobin; hs-CRP < 1.0 mg/L (K64.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fecal Calprotectin [Hemorrhoids K64.9] | < 50 mcg/g (K64.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Hemorrhoids
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Lidocaine HCl and Hydrocortisone Acetate Lidocaine HCl - Hydrocortisone Acetate, Lidocaine HCl 3% and Hydrocortisone Acetate1% Cream • RxCUI 1012223 | Amide Local Anesthetic | 78% | $0.8747 | $ 43.93 /mo |
| Lidocaine 4% Relaxink Lidocaine, Healthwise Lidocaine Pain Relief • RxCUI 1421893 | Amide Local Anesthetic | 77% | $0.0989 | $ 12.50 /mo |
| Hydrocortisone Acetate Medi-First Hydrocortisone 1%, Medi First Plus • RxCUI 1291082 | Corticosteroid | 88% | $0.0537 | $ 6.55 /mo |
| Lidocaine, Phenylephrine Hydrochloride The Femme Fix Hemorrhoid Treatment, Numb520 • RxCUI 2673304 | Amide Local Anesthetic | 77% | $0.0989 | $ 12.50 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hemorrhoids)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn's The Urgency NRS demonstrated strong psychometric properties in the VIVID-1 population of moderately to severely active CD. Advances in therapy • 2025-02-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39692838 ↗ |
Hemorrhoids Patient Community & “People Like Me” Threads
Filter Hemorrhoids community threads and patient logs by age, biological sex, dosage, and treatment duration.